Ex-Valeant Pharmaceuticals Exec, Philidor Rx Services CEO, Charged In Alleged Kickback Scheme

Posted: Updated:
Print

NEW YORK — U.S. prosecutors are charging a former executive with Quebec-based Valeant Pharmaceuticals and the former CEO of Philidor Rx Services, alleging they were involved in a multimillion-dollar fraud and kickback scheme.

The U.S. Attorney's Office for the Southern District of New York says it will hold a news conference later today to announce charges against Gary Tanner, a former executive at Valeant Pharmaceuticals International Inc. (TSX:VRX), and Andrew Davenport, the former CEO of Philidor Rx Services.

More Coming.